Fig. 7From: How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncologyPSMA-PET (a) in a patient with prostate cancer shows a focus of high uptake intracranially (arrow). The post-contrast MRI (b), however, demonstrates much more widespread intracranial metastatic disease (arrowheads)Back to article page